Search
Search Results
##search.searchResults.foundPlural##
-
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3742PDF: 1561HTML: 8031Randi Fig: 181 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1309PDF: 862HTML: 1032Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 175 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2788PDF: 1116HTML: 11215 -
SOLITARY PLASMACYTOMA
3850PDF: 2175HTML: 1220fIGURES 1,2: 213 -
Identification of Alpha Thalassemia, RNF 213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome Alpha Thalassemia and RNF 213 Gene Mutation in Moyamoya
952PDF: 716HTML: 231 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1807PDF: 808HTML: 10234Figures 1,2,3: 173 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1960PDF: 811HTML: 221 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
733PDF: 838PDF Supp. Files: 78HTML: 189 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1385PDF: 816HTML: 3123 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2486PDF: 922HTML: 528 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1965PDF: 747HTML: 694 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2799PDF: 1006HTML: 5519 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1058PDF: 961HTML: 327 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
719PDF: 464HTML: 6265 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4241PDF: 1517HTML: 447 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1278PDF: 719HTML: 320 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1243PDF: 473HTML: 18569Figure 1: 168Figure 2: 150Figure 3: 167Figure 4: 205Figure 5: 176 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4312PDF: 1488HTML: 1547Untitled: 225 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2448HTML: 271PDF: 867 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4488PDF: 1916HTML: 17736
1 - 40 of 40 items







